Molecular evolution

For tomato genes, one plus one doesn't always make two

Retrieved on: 
Monday, April 12, 2021

That is because every individual has a unique set of genetic variations mutationsthat affect how genes act and function.

Key Points: 
  • That is because every individual has a unique set of genetic variations mutationsthat affect how genes act and function.
  • Added together, millions of small genetic variations make it hard to predict how a particular mutation will impact any individual.
  • They generated over 60 tomato mutants by removing little pieces of DNA in the promoter regions, areas near the genes that control their expression.
  • "\nThis range of interactions for any two mutations models the consequences of a single mutation occurring in different genetic backgrounds.

Cognition Therapeutics Elucidates Genetic Mutation that Protects Against Alzheimer’s Disease

Retrieved on: 
Monday, October 19, 2020

It has been well documented that individuals with the A673T mutation (Icelandic mutation) in the protein A are four times less likely to develop Alzheimers disease than are noncarriers, making this the strongest protective mutation discovered to date for this disease.

Key Points: 
  • It has been well documented that individuals with the A673T mutation (Icelandic mutation) in the protein A are four times less likely to develop Alzheimers disease than are noncarriers, making this the strongest protective mutation discovered to date for this disease.
  • Cognition scientists conducted a series of studies to clarify the mechanism by which this genetic mutation confers protection against Alzheimers disease.
  • This suggests that the reduction in oligomer binding is the main reason Icelandic mutation carriers are four times less likely to develop Alzheimers disease.
  • This research will have a profound impact on Alzheimers disease-modifying therapeutic research, as it lays out a clear mechanism for effective Alzheimers therapeutics, concluded Lisa Ricciardi , president and CEO of Cognition Therapeutics.

Bionano Genomics' Saphyr System Shown to be Indispensable for the Analysis of Certain Genetic Disease Causing Variants

Retrieved on: 
Thursday, October 15, 2020

Only Bionanos optical mapping technology can image single molecules that are so long that they span the segmental duplications.

Key Points: 
  • Only Bionanos optical mapping technology can image single molecules that are so long that they span the segmental duplications.
  • These repetitive sequences can interact with each other when sperm or eggs are created and their rearrangement can cause severe genetic disease.
  • Several novel SVs were detected for each locus, and the exact disease causing rearrangement was determined with much higher accuracy than was formerly possible without Saphyr.
  • An increasing number of studies have relied on Bionanos Saphyr system to characterize disease-causing structural variants that could not be correctly analyzed with other molecular techniques.

Industrial-Scale Phenotyping of Cell-Cycle Control in Yeast

Retrieved on: 
Tuesday, May 26, 2020

By focusing their attention on the inner workings of yeast, scientists have made remarkable progress in learning how cells control cell division and growth.

Key Points: 
  • By focusing their attention on the inner workings of yeast, scientists have made remarkable progress in learning how cells control cell division and growth.
  • Synthetic lethal mutations arise when viable yeast cells carrying deletions of two different genes are crossed to produce double-mutant cells that are unable to grow and survive.
  • Genetic interactions derived from high-throughput phenotyping of 6589 yeast cell cycle mutants.
  • The GenoFAB Automation Platform accelerates biomedical research projects by connecting laboratory operations with data services and supply chain transactions.

Registration Now Open for Deep Mutational Scanning Symposium & Workshop Hosted by Brotman Baty Institute and Center for the Multiplex Assessment of Phenotype, Jan. 13 - 14

Retrieved on: 
Thursday, December 12, 2019

SEATTLE, Dec. 12, 2019 /PRNewswire/ -- Brotman Baty Institute for Precision Medicine (BBI) and Center for the Multiplex Assessment of Phenotype will co-sponsor a two-day Deep Mutational Scanning Symposium & Workshop in Seattle on Jan. 13 and 14, 2020.

Key Points: 
  • SEATTLE, Dec. 12, 2019 /PRNewswire/ -- Brotman Baty Institute for Precision Medicine (BBI) and Center for the Multiplex Assessment of Phenotype will co-sponsor a two-day Deep Mutational Scanning Symposium & Workshop in Seattle on Jan. 13 and 14, 2020.
  • The event will consist of a Deep Mutational Scanning Symposium on Monday, Jan. 13, followed by a workshop for participants on Tuesday, Jan. 14.
  • Deep mutational scanning is a cutting-edge method to study the effects of mutations on the function of proteins.
  • Deep mutational scanning has the exciting potential to unlock new treatment avenues for diseases as varied as influenza and Amyotrophic Lateral Sclerosis (ALS).